No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
300406 Beijing Strong Biotechnologies, Inc.
- 12.71
- -0.25-1.93%
Trading Jan 21 10:03 CST
7.48BMarket Cap14.22P/E (TTM)
13.04High12.69Low12.88KlotVolume13.02Open12.96Pre Close16.51MTurnover0.30%Turnover Ratio14.28P/E (Static)588.33MShares21.5852wk High1.97P/B5.39BFloat Cap11.0152wk Low15.55Limit Up424.42MShs Float40.54Historical High10.37Limit Down2.70%Amplitude3.06Historical Low0.20Dividend TTM12.81Avg Price9.54KlotAsk1.57%Div YieldTTM100Lot Size3.15KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Beijing Strong Biotechnologies, Inc.: A wholly-owned subsidiary has completed the filing for the first category of medical instruments.
Express News | Beijing Strong Biotechnologies, Inc.: obtained the medical instruments registration certificate for the cardiac troponin I assay kit (fluorescent immunochromatography method).
Express News | Beijing Strong Biotechnologies, Inc.: The company's executive vice president SHENG DAN has resigned.
Beijing Strong Biotechnologies, Inc. (300406.SZ): China National Pharmaceutical Investment has cumulatively increased its Shareholding by 4.3408 million shares, and the increase has been completed.
On December 24, Gelonghui reported that Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that on December 24, 2024, it received a letter from China Meheco Group, a shareholder holding more than 5% of the shares, regarding the implementation of the Shareholding plan. As of the date of this announcement, the Shareholding plan has been completed, with China Meheco Group increasing its shares by a total of 4,340,800 shares through centralized bidding, accounting for 0.74% of the company's shares with voting rights, with an increase amounting to 62,283,792.00 yuan.
Beijing Strong Biotechnologies Gets Medical Device Registrations for Three Assay Kits
Beijing strong biotechnologies, inc. (300406.SZ): Obtained the medical instruments registration certificate for interleukin-6 assay kit.
On November 13, Gelunhui announced that on November 13, 2024, Beijing Strong Biotechnologies, Inc. (300406.SZ) received the medical instruments registration certificate issued by the Peking Pharmaceutical Supervision and Administration Bureau, with the product name as Interleukin 6 assay kit (chemiluminescent immunoassay with magnetic microparticles). This assay kit is used for the quantitative determination of Interleukin 6 (IL-6) content in human serum or plasma.